Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks 
Samsung Electronics Shares Jump on HBM4 Mass Production Report 
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade 
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms 
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan 
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss 
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins 
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring 
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion 
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions 
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves 
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year 
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week 
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push 
BUENA, N.J., March 13, 2018 -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at the Oppenheimer 28th Annual Healthcare Conference. The Conference is taking place March 20-21, 2018 at the Westin Grand Central, New York, NY.
Jason Grenfell-Gardner, President and CEO and Damian Finio, Chief Financial Officer of Teligent, Inc. will present on Tuesday March 20th at 8:00 a.m. ET.
The presentation will be webcast and will be accessible online on the investors section of the Company's website at http://www.teligent.com. A replay will be available for 30 days.
About Teligent, Inc.
Teligent is a specialty generic pharmaceutical company. Our mission is to be a leading player in the specialty generic prescription drug market. Learn more on our website www.teligent.com.
Contact:
Damian Finio
Teligent, Inc.
(856) 336-9117
www.teligent.com
